CG MedTech Co.,Ltd. (KOSDAQ:056090)

Market Cap	129.18B
Revenue (ttm)	45.59B
Net Income (ttm)	3.85B
Shares Out	103.26M
EPS (ttm)	32.60
PE Ratio	38.37
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,481,110
Average Volume	1,457,205
Open	1,133.00
Previous Close	1,139.00
Day's Range	1,130.00 - 1,308.00
52-Week Range	830.00 - 1,308.00
Beta	-0.77
RSI	77.91
Earnings Date	Aug 14, 2025

About CG MedTech

CG MedTech Co.,Ltd. researches, develops, manufactures, and sale of orthopedic medical devices in the healthcare service market. The company offers headless screws, cortex screws, and K-wires and pin; Aspiron and Maxima anterior cervical plate systems for use in anterior interbody screw/plate fixation of the cervical spine; ANAX OCT spinal system, a device for spinal surgery; Velofix PEEK SA cervical cages for cervical interbody fusion; and Velofix PEEK cage; and NeoIC PEEK cage, devices used with autograft or bone graft substitutes, as well as...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1993
• Employees: 120
• Stock Exchange: KOSDAQ
• Ticker Symbol: 056090

Financial Performance

In 2024, CG MedTech's revenue was 34.62 billion, a decrease of -0.99% compared to the previous year's 34.97 billion. Earnings were 59.69 million, a decrease of -96.34%.